Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medical Marijuana Inc MJNA

Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in four divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news... see more

Recent & Breaking News (OTCPK:MJNA)

Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Recent Federal Court Ruling on Delta-8 THC; Launches New Hemp Products

GlobeNewswire May 31, 2022

Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies

GlobeNewswire May 26, 2022

Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes

GlobeNewswire May 23, 2022

Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results

GlobeNewswire May 19, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study

GlobeNewswire May 18, 2022

Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company

GlobeNewswire May 12, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Direct Sales Veteran Eric Glenn as Entrepreneur

GlobeNewswire May 11, 2022

Medical Marijuana, Inc. Honored as Silver Stevie Award Winner in the 2022 American Business Awards®

GlobeNewswire April 28, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community

GlobeNewswire April 21, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa Division in March 2022

GlobeNewswire April 14, 2022

Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives

GlobeNewswire April 7, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Included on New FSA List of CBD Novel Food Applicants

GlobeNewswire April 4, 2022

Medical Marijuana, Inc. Reports $34.1 Million in Revenue in 2021 Annual Financial and Operational Results Filing

GlobeNewswire April 1, 2022

Medical Marijuana, Inc. Issues New Letter to Shareholders

GlobeNewswire March 29, 2022

Medical Marijuana, Inc. Satisfies Major Outstanding Convertible Debt

GlobeNewswire March 10, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague

GlobeNewswire March 1, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium

GlobeNewswire February 24, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022

GlobeNewswire February 15, 2022

Medical Marijuana, Inc. Promotes Chief Financial and Information Officer Todd Morrow to Company President

GlobeNewswire February 10, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Johannesburg, South Africa

GlobeNewswire February 1, 2022